Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127609541 | 12760954 | 1 | I | 2009 | 20160901 | 20160919 | 20160919 | PER | US-ASTRAZENECA-2016SE93700 | ASTRAZENECA | 70.00 | YR | M | Y | 83.90000 | KG | 20160920 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127609541 | 12760954 | 1 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 340 | MG | N | U | 0 | 5 | MG | TABLET | QD | |||
127609541 | 12760954 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 340 | MG | N | U | 0 | 5 | MG | TABLET | QD | |||
127609541 | 12760954 | 3 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 340 | MG | N | U | 0 | 20 | MG | TABLET | QD | |||
127609541 | 12760954 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 340 | MG | N | U | 0 | 20 | MG | TABLET | QD | |||
127609541 | 12760954 | 5 | PS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 51140 | MG | N | 21229 | 20 | MG | MODIFIED-RELEASE TABLET | QD | ||||
127609541 | 12760954 | 6 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 600 | MG | N | U | 0 | 20 | MG | TABLET | QD | |||
127609541 | 12760954 | 7 | SS | BRILINTA | TICAGRELOR | 1 | Oral | 2520 | MG | N | U | 0 | 90 | MG | TABLET | BID | |||
127609541 | 12760954 | 8 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Unknown | 25.0MG UNKNOWN | 0 | 25 | MG | ||||||||
127609541 | 12760954 | 9 | C | MELOXICAM. | MELOXICAM | 1 | 0 | 15 | MG | QD | |||||||||
127609541 | 12760954 | 10 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
127609541 | 12760954 | 11 | C | BABY ASPIRIN | ASPIRIN | 1 | DAILY | 0 | |||||||||||
127609541 | 12760954 | 12 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | 75 | MG | QD | |||||||||
127609541 | 12760954 | 13 | C | ATIVAN | LORAZEPAM | 1 | 0.5MG AS NEEDED | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127609541 | 12760954 | 1 | Hypertension |
127609541 | 12760954 | 2 | Dyspnoea |
127609541 | 12760954 | 3 | Hypertension |
127609541 | 12760954 | 4 | Dyspnoea |
127609541 | 12760954 | 6 | Coronary artery disease |
127609541 | 12760954 | 7 | Coronary arterial stent insertion |
127609541 | 12760954 | 8 | Cardiac stress test |
127609541 | 12760954 | 9 | Arthralgia |
127609541 | 12760954 | 10 | Coronary artery disease |
127609541 | 12760954 | 12 | Antiplatelet therapy |
127609541 | 12760954 | 13 | Dyspnoea |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127609541 | 12760954 | Arthralgia | |
127609541 | 12760954 | Bone disorder | |
127609541 | 12760954 | Dyspnoea | |
127609541 | 12760954 | Haemochromatosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127609541 | 12760954 | 1 | 20160725 | 20160801 | 0 | |
127609541 | 12760954 | 2 | 20160725 | 20160801 | 0 | |
127609541 | 12760954 | 3 | 20160802 | 20160816 | 0 | |
127609541 | 12760954 | 4 | 20160802 | 20160816 | 0 | |
127609541 | 12760954 | 5 | 2009 | 2016 | 0 | |
127609541 | 12760954 | 6 | 20160718 | 20160816 | 0 | |
127609541 | 12760954 | 7 | 20160712 | 20160725 | 0 | |
127609541 | 12760954 | 8 | 2016 | 0 | ||
127609541 | 12760954 | 9 | 2009 | 2016 | 0 | |
127609541 | 12760954 | 10 | 20160717 | 20160718 | 0 | |
127609541 | 12760954 | 11 | 2016 | 0 | ||
127609541 | 12760954 | 12 | 20160725 | 0 |